On June 9, the Food and Drug Administration approved the first effective vaccine against Human Papillomavirus, a sexually transmitted infection that is one of the major causes of cervical cancer. On the heels of this approval, which represents a crucial breakthrough in the efforts of scientists, doctors and public health officials to combat the spread of STD’s in the United States and elsewhere, the Medical College of Georgia announced today that significant strides have been made towards...